Combined parathyroid hormone+alendronate therapy versus PTH monotherpy for osteoporosis
Parathyroid Hormone Plus Alendronate in Osteoporosis: A Meta-Analysis of Randomized Controlled TrialsJ Invest Surg. 2015 Dec;28(6):309-16
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
6 randomized controlled trials, including a total of 833 patients, were analyzed to evaluate the efficacy of combined parathyroid hormone (PTH) and alendronate administration in the treatment of osteoporosis. The meta-analysis assessed mean percent increases in bone mineral density (BMD) at the lumbar spine, femoral neck, total hip, and distal radius with combination therapy compared to monothera...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE